ALPHA TAU MEDICAL LTD
DRTS · NASDAQ
Updated at 2026-10-14 08:42:09
- Today's High
- $14.25
- Today’s Low
- $13.65
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $14.42
- Previous Close
- $14.26
- Volume
- 281.46K
- Market Cap
- $1.31B
- P/E Ratio
- --
- EPS
- $-0.65
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Health Care
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- KIRYAT HAMADA ST. 5, JERUSALEM, ISRAEL, 9777605
- Country
- IL
- Listing Date
- 2022-03-08
- Fiscal Year End
- December
- Shares Outstanding
- 90.33M
- CIK
- 0001871321
- Website
- www.alphatau.com
Alpha Tau Medical Ltd., a clinical-stage oncology therapies company, is engaged in the research, development, and commercialization of alpha-emitting radiation therapy (Alpha DaRT) for the treatment of solid cancer in Israel and the United States. The company is headquartered in Jerusalem, Israel.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$13.78M
2026-03-31
$13.31M
2025-12-31
$12.6M
2025-09-30
$10.73M
Net Income
2026-06-30
-$45.81M
2026-03-31
-$22.93M
2025-12-31
-$12.13M
2025-09-30
-$11.68M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.50
2026-03-31
$-0.26
2025-12-31
$-0.14
2025-09-30
$-0.14
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$13.78M
2026-03-31
-$13.31M
2025-12-31
-$11.24M
2025-09-30
-$10.73M
Effective Tax Rate
2026-06-30
-0.5%
2026-03-31
0.04%
2025-12-31
0.28%
2025-09-30
0.06%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $13.78M | $13.31M | $12.6M | $10.73M |
| Net Income | -$45.81M | -$22.93M | -$12.13M | -$11.68M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.50 | $-0.26 | $-0.14 | $-0.14 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$13.78M | -$13.31M | -$11.24M | -$10.73M |
| Effective Tax Rate | -0.5% | 0.04% | 0.28% | 0.06% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.